Dyne Therapeutics, Inc. Files SEC Form 4, Statement of Changes in Beneficial Ownership of Securities: (Oct. 22, 2024).

Dyne Therapeutics, Inc. filed a Form 4 with the U.S. Securities and Exchange Commission on October 22, 2024. This filing is a statement of changes in beneficial ownership of securities, as required by the SEC for directors, officers, or owners of more than ten percent of a class of equity securities. The document provides contact information for Dyne Therapeutics, Inc. and can be accessed on the SEC's website for further details. [Extracted from the article]